Safety in numbers: risankizumab for moderate‐to‐severe psoriasis
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Dermatology"
DOI: 10.1111/bjd.20947
Abstract: rangements in epithelioid hemangioma: a molecular study of 58 cases with morphologic reappraisal. Am J Surg Pathol 2015; 39:1313–21. 4 Antonescu CR, Chen HW, Sung YS et al. ZFP36-FOSB fusion defines a subset of epithelioid… read more here.
Keywords: epithelioid hemangioma; risankizumab moderate; molecular study; hemangioma ... See more keywords